| Sep 23, 2026 | Viviane Monges | — | SELL-OPTIONS | — | $20.55 | $299K |
| Sep 22, 2026 | Johannes Schikan | — | SELL-OPTIONS | — | $28.09 | $13K |
| Sep 21, 2026 | David W Nassif | CFO / CLO | SELL | 6.500K | $36.47 | $219K |
| Sep 17, 2026 | Peng Lu | PRESIDENT | SELL-OPTIONS | — | $18.80 | $3.2M |
| Sep 17, 2026 | Johannes Schikan | — | SELL | 200.000K | $35.00 | $7.0M |
| Sep 17, 2026 | Elisabeth Bjork | — | SELL-OPTIONS | — | $26.77 | $1.2M |
| Sep 17, 2026 | Robert Glassman | — | SELL-OPTIONS | — | $28.35 | $296K |
| Sep 17, 2026 | Anne | CHIEF EARLY DEVELOPMENT | SELL | 20.000K | $38.27 | $765K |
| Sep 15, 2026 | Stefan Abele | CHIEF TECHNICAL OPS OFFICER | SELL | 1.400K | $27.29 | $1.0M |
| Sep 15, 2026 | Robert Glassman | — | SELL-OPTIONS | — | $30.29 | $138K |
| Sep 14, 2026 | Wim Souverjins | CHIEF COMMERCIAL OFFICER | SELL | 6.090K | $28.33 | $675K |
| Sep 14, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.291K | $39.40 | $90K |
| Sep 11, 2026 | Peng Lu | PRESIDENT | SELL | 226.000 | $21.34 | $572K |
| Sep 10, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL-OPTIONS | — | $23.18 | $908K |
| Sep 9, 2026 | Robert Glassman | — | SELL-OPTIONS | — | $28.77 | $140K |
| Sep 8, 2026 | Peng Lu | PRESIDENT | SELL-OPTIONS | — | $21.63 | $571K |
| Aug 14, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $34.77 | $80K |
| Jul 13, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $34.97 | $80K |
| Jun 29, 2026 | Johannes Schikan | — | SELL | 37.600K | $35.41 | $1.3M |
| Jun 29, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 37.700K | $21.12 | $2.4M |
| Jun 29, 2026 | Johannes Schikan | — | SELL | 2.400K | $35.10 | $84K |
| Jun 25, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 2.300K | $19.92 | $151K |
| Jun 25, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $18.45 | $942K |
| Jun 18, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $18.30 | $9K |
| Jun 15, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.291K | $31.07 | $71K |
| Jun 4, 2026 | Anna Nijdam | PRINCIPAL ACCOUNTING OFFICER | SELL | 2.670K | $30.87 | $82K |
| May 21, 2026 | Viviane Monges | — | SELL | 9.667K | $30.29 | $293K |
| May 21, 2026 | Anna Nijdam | PRINCIPAL ACCOUNTING OFFICER | SELL-OPTIONS | — | $25.35 | $78K |
| May 21, 2026 | David W Nassif | CFO / CLO | SELL | 10.000K | $30.31 | $303K |
| May 20, 2026 | Elisabeth Bjork | — | SELL-OPTIONS | — | $18.68 | $213K |
| May 18, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $29.22 | $67K |
| May 15, 2026 | Robert Glassman | — | SELL | 4.667K | $26.07 | $179K |
| May 15, 2026 | Stefan Abele | CHIEF TECHNICAL OPS OFFICER | SELL | 8.748K | $29.82 | $261K |
| May 15, 2026 | Wim Souverijins | CHIEF COMMERCIAL OFFICER | SELL | 10.000K | $29.92 | $299K |
| May 1, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.38 | $391K |
| Apr 29, 2026 | Johannes Schikan | — | SELL | 32.900K | $30.29 | $997K |
| Apr 29, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 22.900K | $18.34 | $1.3M |
| Apr 29, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.40 | $517K |
| Apr 22, 2026 | Johannes Schikan | — | SELL | 7.100K | $30.05 | $213K |
| Apr 22, 2026 | Anne Lesage | CHIEF EARLY DEVELOPMENT | SELL | 7.100K | $18.83 | $384K |
| Apr 22, 2026 | Peng Lu | CHIEF MEDICAL OFFICER | SELL-OPTIONS | — | $16.32 | $195K |
| Apr 16, 2026 | Berndt Modig | CHIEF EXECUTIVE OFFICER | SELL | 2.292K | $28.60 | $66K |
